All In MedTech

Device Trial Radar · NCT07556185

MedlyPeds Feasibility Study

MedlyPeds Feasibility Study: A Mobile, Smartdevice Based Telemonitoring for Pediatric Heart Disease, a Prospective Cohort Study

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jul 28, 2026

Primary completion

Dec 2028

Study completion Dec 2029

Sponsor

Lead sponsor
The Hospital for Sick ChildrenAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University Health Network, Toronto
First posted
Apr 29, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 8 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

SickKids and UHN have developed MedlyPeds which is a smart phone application designed to remotely monitor patients with heart disease. This is a feasibility study which will enroll up to 30 patients with different types of heart disease to see which patient types may benefit the most from MedlyPeds if it were to be used for clinical monitoring. The study is gathering feedback about the app from patients, parents and clinicians to confirm how it needs to be modified to better serve the purpose in a future trial.

Conditions

  • Pediatric Heart Failure
  • Congenital Heart Disease (CHD)
  • Acquired Heart Disease
  • Pulmonary Hypertension
  • Post Cardiac Surgery

Interventions

  • MedlyPeds AppDevice

    The mobile phone-based telemonitoring system (MedlyPeds) will enable cardiac patients to monitor their weight, blood pressure, and heart rate, using wireless home medical devices. In addition, they will answer questions about their symptoms and wellness using their mobile phone. The device measurements will be automatically and wirelessly transmitted to the mobile phone and then to a data server. Automated and individualized self-care messages, developed with the assistance of healthcare providers, will subsequently be sent to the patient based on the readings and reported symptoms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of MedlyPeds App Daily Check-In CompletionTime frame: 3 months
  2. Feasibility and acceptability of Medly PedsTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Hospital for Sick Children

    Toronto, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.